Abbvie finalizes deal to buy Botox maker Allergan for $63 billion Medical Dialogues Bureau26 Jun 2019 10:00 AM ISTA note from Moody's affirmed Abbvie's debt rating, saying a plan to reduce debt through existing blockbusters like AbbVie's Humira and Imbruvica and...
Sage shares surge as depression drug succeeds in mid-stage trial Ruby Khatun Khatun9 Dec 2017 9:30 AM ISTDrug developer Sage Therapeutics Inc's shares soared as much as 85 percent to a record high on Thursday after its experimental drug to reduce the...
Suven Life Sciences gets patents from India, US, Hong Kong on neurological molecule Ruby Khatun Khatun17 Nov 2017 10:00 AM ISTNew Delhi: Suven Life Sciences said it has been granted a patent each from Hong Kong and the US and two from India for treatment of disorders...